Related Experiment Video
Updated: Jun 3, 2026
04:05
A Rat Model of Pouchitis Following Proctocolectomy and Ileal Pouch-Anal Anastomosis Using Dextran Sulfate Sodium
Published on: May 31, 2024
How to manage pouchitis in ulcerative colitis?
F Magro1, S Lopes, S Rodrigues
1Gastroenterology Department, Hospital de São João. Porto, Portugal. fm@med.up.pt
Current Drug Targets
|April 7, 2011
Summary
Pouchitis affects 50% of ulcerative colitis patients post-ileal pouch-anal anastomosis (IPAA) surgery. Ciprofloxacin shows promise for acute cases, while probiotics are recommended for preventing pouchitis.
Area of Science:
- Gastroenterology
- Surgical Outcomes
- Inflammatory Bowel Disease
Background:
- Ileal pouch-anal anastomosis (IPAA) is a surgical option for ulcerative colitis (UC).
- Pouchitis, inflammation of the ileal pouch, affects up to 50% of patients post-IPAA.
- Risk factors include preoperative extraintestinal manifestations and primary sclerosing cholangitis.
Purpose of the Study:
- To review the management strategies for pouchitis following IPAA surgery for UC.
- To evaluate the efficacy of different therapeutic options for acute and chronic pouchitis.
- To highlight the role of probiotics in pouchitis prophylaxis.
Main Methods:
- Review of existing literature on pouchitis treatment and prevention.
- Analysis of antibiotic efficacy in acute and chronic pouchitis.
- Evaluation of novel therapeutic approaches including probiotics and infliximab.
Main Results:
- Ciprofloxacin may be more effective and less toxic than metronidazole for acute pouchitis.
- Antibiotics have limited efficacy in chronic pouchitis, often requiring maintenance therapy.
- Combination antibiotic therapy or infliximab may be effective for refractory cases.
Conclusions:
- Probiotics are recommended for both primary and secondary prophylaxis of pouchitis.
- Management strategies should be tailored to acute versus chronic pouchitis.
- Further research into optimizing long-term pouchitis management is warranted.
Related Concept Videos
01:21Inflammatory Bowel Disease V: Surgical Management
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
01:26Peptic Ulcer Disease IV: Management
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
01:25Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...